GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

Ed Mahon reported this story while participating in the USC Annenberg Center for Health Journalism’s 2024 Data Fellowship and received engagement mentoring and funding. Spotlight PA is ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

I f your job involves sitting in front of a screen all day, there’s a good chance your eyes are paying the price. After hours ...

Darker tints, like brown or amber, are common and work well for everyday use, REI reported. Brown offers a multitude of benefits that make it such a popular color. It helps protect your eyes by ...

Every year, tens of thousands of Americans die from opioid use. Ther were 82,000 opioid-involved overdose deaths in 2022, according to the US Centers for Disease Control and Prevention. The US gets 30 ...

With an effective alternative now available, it could have a profound impact on reducing opioid use and its associated risks in the state. Here is everything you need to know. The FDA on Thursday ...

The approval marks the first new class of pain medicine in more than two decades and offers a potential non-addictive alternative to opioids. "Today's approval is a historic milestone for the 80 ...